Independent Predictors Analysis and Model Construction of Cavitary Central Lung Cancer

• Conditions: Central Lung Cancer

• Registration Number: NCT05278754
• Lead Sponsor: The Central Hospital of Lishui City

Brief Summary

This study is a retrospective, multicenter clinical study. The main goal is to identify the risk factors for cavity formation in central-type lung cancer lesions, and to construct a prediction model for cavity formation in central-type lung cancer lesions based on the above risk factors.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-02-10
• Status Verified: 2022-03
• Study First Submitted QC: 2022-03-03
• Last Update Submitted: 2022-03-03
• Study Start: 2022-03-12
• Study First Posted: 2022-03-14
• Last Update Posted: 2022-03-14
• Primary Completion: 2022-05-12
• Study Completion: 2022-08-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1. Age：older than 18 years；
2. Clinical or pathologically confirmed central lung cancer;
3. Lesions without cavities at first diagnosis of central lung cancer;
4. Performed complete laboratory and imaging research at the first diagnosis of the central lung cancer;
5. Patients with cavities formation during follow up, and the cavities were independently confirmed by at least 3 imaging experts;
6. Patients with complete medical records;

Exclusion Criteria

1. Patients suffering other malignant tumors;
2. Patients missing the imaging data;
3. Patients missing the clinical data.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Formation of cavities in the central lung cancer, assessed up to 18 months.	Time from enrollment to the time of cavities formation, assessed up to 18 months.	Time from enrollment to the time of cavities formation, assessed up to 18 months.

Secondary Outcome Measures

Name	Time	Method
Hemoptysis in patients with central lung cancer, assessed up to 18 months.	Time from enrollment to hemoptysis, assessed up to 18 months.	Time from enrollment to hemoptysis, assessed up to 18 months.